Benzoxazines for use in the treatment of parkinson's disease

   
   

Benzoxazines of Formula (I) wherein R.sup.1 is C.sub.1 -C.sub.6 alkyl, C.sub.2 -C.sub.6 alkenyl, or (CH.sub.2).sub.n phenyl, R.sup.2 is C.sub.3 -C.sub.6 alkyl, R.sup.3 is hydrogen, halo, hydroxy, alkoxy, or alkylthio, R.sup.4 is hydrogen or alkyl, or a pharmaceutically acceptable salt thereof, are useful for treating movement disorders such as Parkinson's disease. ##STR1##

Benzoxazines del fórmula (i) en donde R.sup.1 es C.sub.1 - C.sub.6 alkyl, C.sub.2 - el alkenyl C.sub.6, o (el fenilo de CH.sub.2).sub.n, R.sup.2 es C.sub.3 - C.sub.6 el alkyl, R.sup.3 es hidrógeno, halo, hydroxy, alkoxy, o alkylthio, R.sup.4 es hidrógeno o alkyl, o una sal farmacéutico aceptable de eso, es útil para tratar desórdenes del movimiento tales como enfermedad de Parkinson. ## del ## STR1

 
Web www.patentalert.com

< Methods of treating disorders with Group I mGluR antagonists

< Peptides having antiangiogenic activity

> Prevention and treatment of degenerative diseases by glutathione and phase II detoxification enzymes

> Electrophoretic display and novel process for its manufacture

~ 00141